Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 28;17(1):54.
doi: 10.3390/ph17010054.

Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy

Affiliations
Review

Triterpenes Drug Delivery Systems, a Modern Approach for Arthritis Targeted Therapy

Célia Faustino et al. Pharmaceuticals (Basel). .

Abstract

Arthritis is a major cause of disability. Currently available anti-arthritic drugs, such as disease-modifying anti-rheumatic drugs (DMARDs), have serious side-effects associated with long-term use. Triterpenoids are natural products with known anti-inflammatory properties, and many have revealed efficiency against arthritis both in vitro and in vivo in several animal models, with negligible cytotoxicity. However, poor bioavailability due to low water solubility and extensive metabolism upon oral administration hinder the therapeutic use of anti-arthritic triterpenoids. Therefore, drug delivery systems (DDSs) able to improve the pharmacokinetic profile of triterpenoids and achieve sustained drug release are useful alternatives for targeted delivery in arthritis treatment. Several DDSs have been described in the literature for triterpenoid delivery, including microparticulate and nanoparticulate DDSs, such as polymeric micro and nanoparticles (NPs), polymeric micelles, liposomes, micro and nanoemulsions, and hydrogels. These systems have shown superior therapeutic effects in arthritis compared to the free drugs and are similar to currently available anti-arthritic drugs without significant side-effects. This review focuses on nanocarriers for triterpenoid delivery in arthritis therapy, including osteoarthritis (OA), rheumatoid arthritis (RA) and gout that appeared in the literature in the last ten years.

Keywords: arthritis; drug delivery systems; gout; osteoarthritis; triterpenes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Summary of some clinical and pathogenic features of RA, AO, and Gout. Created with BioRender.com (accessed on 16 December 2023).
Figure 2
Figure 2
Structures of triterpenes with activity on osteoarthritis and gout.
Figure 3
Figure 3
Some DDS for the main triterpenic compounds in rheumathoid arthritis, osteoarthritis, and gouty arthritis. Created with BioRender.com (accessed on 19 December 2023).
Figure 4
Figure 4
Structures of triterpenes incorporated in drug delivery systems (DDSs) with activity on arthritis.

References

    1. Arthritis Foundation Arthritis by the Numbers Book of Trusted Facts & Figures. 2020. [(accessed on 15 February 2023)]. Available online: https://www.arthritis.org/getmedia/73a9f02d-7f91-4084-91c3-0ed0b11c5814/....
    1. Senthelal S., Li J., Ardeshirzadeh S., Thomas M. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Arthritis. - PubMed
    1. Hunter D.J., Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745–1759. doi: 10.1016/S0140-6736(19)30417-9. - DOI - PubMed
    1. Global Burden of Disease Collaborative Network Global Burden of Disease Study 2019 (GBD 2019) Disease and Injury Burden 1990–2019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020. [(accessed on 16 September 2023)]. Available online: https://ghdx.healthdata.org/record/ihme-data/gbd-2019-disease-and-injury....
    1. Faustino C., Pinheiro L., Duarte N. Triterpenes as Potential Drug Candidates for Rheumatoid Arthritis Treatment. Life. 2023;13:1514. doi: 10.3390/life13071514. - DOI - PMC - PubMed

LinkOut - more resources